Skip to content
Skip to content

Independent e-magazine

the OUTSPOKEN digest

World Diabetes Day 2026: Why Early Action Is the Theme and What a New IDF Survey Found

On 14 November the WHO and IDF launch a two-year push on spotting diabetes sooner. Their numbers on undiagnosed cases, a six-country risk survey and the warning signs worth knowing.

Outspoken Digest Health Desk

Saturday, November 14, 2026/3 min read

A single unbranded blood glucose test strip lying on a plain white surface, showing its gold electrode contacts and black alignment dots with no text or logo, photographed on 17 January 2020, a file photograph of a diabetes test strip and not of any person, product brand, campaign event or organisation
Photo: Suyash.dwivedi via Wikimedia Commons (CC BY-SA 4.0)

World Diabetes Day falls today, Saturday 14 November, and its message for the next two years is simple: act early. The World Health Organization's campaign page says more than 40 per cent of people living with diabetes worldwide are undiagnosed, and that type 2 usually develops gradually and may cause few or no noticeable symptoms.

The International Diabetes Federation (IDF), which runs the day with the WHO, puts a number on the gap. In a 10 November release, citing its Diabetes Atlas, it says 589 million adults live with diabetes, about 252 million of them do not know it, and a further 635 million adults are at high risk of type 2. It adds that up to half of people with type 2 already have complications when they are diagnosed.

What did the IDF survey find about diabetes risk?

The same release reports a survey of adults at increased risk of type 2 diabetes in six countries: Brazil, India, Kenya, Saudi Arabia, Spain and the United States. Sixty-seven per cent believed people with prediabetes have noticeable symptoms, and 15 per cent thought they were likely to develop type 2 despite having at least two risk factors. Forty-three per cent said they would not feel confident arranging a risk check, yet 84 per cent said a check is worthwhile even when they feel healthy.

Treat the survey with some care: the IDF page does not give the number of respondents, the fieldwork dates or the polling firm, and it is the campaign organiser's own research. The pattern, though, matches the clinical picture: because type 2 can be silent, people wait for symptoms that may not come.

What are the warning signs and who should be tested?

The WHO lists increased thirst, frequent urination, tiredness and blurred vision as common symptoms, and unexplained weight loss among them. It says type 1 can develop rapidly and at any age and is often missed or misdiagnosed in adults. The IDF's campaign asks people to learn the warning signs of type 1 and to seek urgent medical advice if they appear, and points to an online type 2 risk assessment; its campaign site says more than 330,000 people have used it.

Local screening advice varies by country. A 10 November column in the Jefferson City News Tribune, written by a diabetes educator, notes that the American Diabetes Association recommends regular screening for adults aged 35 and older in the United States. In the Gulf, where Saudi Arabia was one of the survey countries, residents should ask their own clinic what its testing guidance is, rather than rely on a global figure.

What does the WHO want governments to do?

Its page restates five coverage targets for 2030 that member states endorsed in 2022: 80 per cent of people with diabetes diagnosed, 80 per cent of those with good glycaemic control, 80 per cent with good blood pressure control, 60 per cent of people aged 40 and over on statins, and affordable insulin and glucose self-monitoring for every person with type 1. It also calls diabetes stigma widespread, harmful and preventable.

This article is reporting, not medical advice. If you have symptoms, a family history or other risk factors, or if you are thinking about changing medication, diet or activity, talk to a clinician who knows your history. Do not stop or adjust any treatment on the strength of a news report.

The campaign runs through 2027, so expect more of the same: risk checks, screening drives and pressure on health ministries to turn the 2030 targets into funded programmes.

Published in The Outspoken Digest

Editorial desk

Outspoken Digest Health Desk

Medicine, public health and the research behind the headlines, read carefully.

Newsletter

The Digest, in your inbox

One edition, sent when it is ready. No noise, and your address is never passed on.

We send a confirmation first. One click to leave, always.

Share this story

the OUTSPOKEN digest

Beyond boundaries. Independent stories on technology, culture, and the trends shaping how we live.